UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

µPhos: a scalable and sensitive platform for high-dimensional phosphoproteomics

Molecular systems biology, 2024-08, Vol.20 (8), p.972-995

2024

Volltextzugriff (PDF)

EZH2 in Myeloid Malignancies

Cells (Basel, Switzerland), 2020-07, Vol.9 (7), p.1639

2020

Volltextzugriff (PDF)

S156: FRONTLINE ASCIMINIB COMBINATION IN CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS. THE FASCINATION TRIAL

HemaSphere, 2023-08, Vol.7 (S3), p.e34543a6-n/a

2023

Volltextzugriff (PDF)

CML - Not only BCR-ABL1 matters

Best practice & research. Clinical haematology, 2020-09, Vol.33 (3), p.101194-101194, Article 101194

2020

Volltextzugriff (PDF)

Treatment-free remission after third-line therapy with asciminib in chronic myeloid leukemia with an atypical e19a2 BCR::ABL1 transcript and T315I mutation

Leukemia, 2024-09, Vol.38 (9), p.2037-2040

2024

Volltextzugriff (PDF)

Durable remission with ruxolitinib in a chronic neutrophilic leukemia patient harboring a truncation and membrane proximal CSF3R compound mutation

Annals of hematology, 2021-02, Vol.100 (2), p.581-584

2021

Volltextzugriff (PDF)

Frequent ASXL1 mutations in children and young adults with chronic myeloid leukemia

Leukemia, 2018-09, Vol.32 (9), p.2046-2049

2018

Volltextzugriff (PDF)

Molecular-defined clonal evolution in patients with chronic myeloid leukemia who were exposed to ionizing radiation following the Chernobyl nuclear disaster

Leukemia, 2020-02, Vol.34 (2), p.645-650

2020

Volltextzugriff (PDF)

Molecular‐defined clonal evolution in patients with classical myeloproliferative neoplasms

British journal of haematology, 2023-07, Vol.202 (2), p.308-317

2023

Volltextzugriff (PDF)

ASXL1 mutations predict inferior molecular response to nilotinib treatment in chronic myeloid leukemia

Leukemia, 2022-09, Vol.36 (9), p.2242-2249

2022

Volltextzugriff (PDF)

ASXL1 Mutations Predict Inferior Molecular Response to Nilotinib Treatment in Newly Diagnosed Patients with Chronic Myeloid Leukemia in Chronic Phase

Blood, 2022-11, Vol.140 (Supplement 1), p.807-808

2022

Volltextzugriff (PDF)

Prevalence and dynamics of clonal hematopoiesis caused by leukemia-associated mutations in elderly individuals without hematologic disorders

Leukemia, 2020-08, Vol.34 (8), p.2198-2205

2020

Volltextzugriff (PDF)

Anti-CD19 CAR-T cells are effective in severe idiopathic Lambert-Eaton myasthenic syndrome

Cell reports. Medicine, 2024-10, p.101794, Article 101794

2024

Volltextzugriff (PDF)

EZH2 mutations and promoter hypermethylation in childhood acute lymphoblastic leukemia

Journal of cancer research and clinical oncology, 2016-07, Vol.142 (7), p.1641-1650

2016

Volltextzugriff (PDF)

Prevalence and Dynamics of Clonal Hematopoiesis Caused By Leukemia Associated Mutations in Elderly Individuals without Hematologic Disorders

Blood, 2017-12, Vol.130, p.1141-1141

2017

Volltextzugriff (PDF)

Only SETBP1 hotspot mutations are associated with refractory disease in myeloid malignancies

Journal of cancer research and clinical oncology, 2017-12, Vol.143 (12), p.2511-2519

2017

Volltextzugriff (PDF)

5-Azacytidine modulates CpG methylation levels of EZH2 and NOTCH1 in myelodysplastic syndromes

Journal of cancer research and clinical oncology, 2019-11, Vol.145 (11), p.2835-2843

2019

Volltextzugriff (PDF)

Genotyping of 25 leukemia-associated genes in a single work flow by next-generation sequencing technology with low amounts of input template DNA

Clinical chemistry (Baltimore, Md.), 2013-08, Vol.59 (8), p.1238-1250

2013

Volltextzugriff (PDF)

Prevalence and Dynamics of BCR-ABL Independent Gene Mutations in Patients with Chronic Myeloid Leukemia

Blood, 2016-12, Vol.128 (22), p.1221-1221

2016

Volltextzugriff (PDF)

Continuous molecular remission and regression of side effects after discontinuation of salvage therapy with sorafenib and donor lymphocyte infusions in a young patient with relapsed AML

Annals of hematology, 2016-05, Vol.95 (6), p.1027-1030

2016

Volltextzugriff (PDF)

Molecularly Defined Clonal Evolution in Patients with Chronic Myeloid Leukemia Independent of the BCR-ABL Status

Blood, 2014-12, Vol.124 (21), p.4513-4513

2014

Volltextzugriff (PDF)

Activating CBL mutations are associated with a distinct MDS/MPN phenotype

Annals of hematology, 2012-11, Vol.91 (11), p.1713-1720

2012

Volltextzugriff (PDF)

Frequency and Clinical Presentation of Polycomb Repressive Complex 2 (PRC2) Component Mutations in Childhood Acute Lymphoblastic Leukemia

Blood, 2012-11, Vol.120 (21), p.1474-1474

2012

Volltextzugriff (PDF)

1 – 25 von 43

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(41)

Publikationsform

Artikel
(42)
Berichte
(1)

Sprache

Englisch
(43)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

µPhos: a scalable and sensitive platform for high-dimensional phosphoproteomics

EZH2 in Myeloid Malignancies

S156: FRONTLINE ASCIMINIB COMBINATION IN CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS. THE FASCINATION TRIAL

S157: NILOTINIB VS. NILOTINIB + PEG‐INTERFERON ΑLPHA INDUCTION AND NILOTINIB OR PEG‐INTERFERON ΑLPHA MAINTENANCE THERAPY FOR NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA PATIENTS. THE TIGER TRIAL

CML - Not only BCR-ABL1 matters

Treatment-free remission after third-line therapy with asciminib in chronic myeloid leukemia with an atypical e19a2 BCR::ABL1 transcript and T315I mutation

Durable remission with ruxolitinib in a chronic neutrophilic leukemia patient harboring a truncation and membrane proximal CSF3R compound mutation

Frequent ASXL1 mutations in children and young adults with chronic myeloid leukemia

Molecular-defined clonal evolution in patients with chronic myeloid leukemia who were exposed to ionizing radiation following the Chernobyl nuclear disaster

Molecular‐defined clonal evolution in patients with classical myeloproliferative neoplasms

ASXL1 mutations predict inferior molecular response to nilotinib treatment in chronic myeloid leukemia

ASXL1 Mutations Predict Inferior Molecular Response to Nilotinib Treatment in Newly Diagnosed Patients with Chronic Myeloid Leukemia in Chronic Phase

Prevalence and dynamics of clonal hematopoiesis caused by leukemia-associated mutations in elderly individuals without hematologic disorders

Treatment Free Remission after Nilotinib Plus Peg-Interferon Alpha Induction and Peg-Interferon Alpha Maintenance Therapy for Newly Diagnosed Chronic Myeloid Leukemia Patients; The Tiger Trial

Anti-CD19 CAR-T cells are effective in severe idiopathic Lambert-Eaton myasthenic syndrome

EZH2 mutations and promoter hypermethylation in childhood acute lymphoblastic leukemia

Prevalence and Dynamics of Clonal Hematopoiesis Caused By Leukemia Associated Mutations in Elderly Individuals without Hematologic Disorders

Only SETBP1 hotspot mutations are associated with refractory disease in myeloid malignancies

5-Azacytidine modulates CpG methylation levels of EZH2 and NOTCH1 in myelodysplastic syndromes

Genotyping of 25 leukemia-associated genes in a single work flow by next-generation sequencing technology with low amounts of input template DNA

Prevalence and Dynamics of BCR-ABL Independent Gene Mutations in Patients with Chronic Myeloid Leukemia

Continuous molecular remission and regression of side effects after discontinuation of salvage therapy with sorafenib and donor lymphocyte infusions in a young patient with relapsed AML

Molecularly Defined Clonal Evolution in Patients with Chronic Myeloid Leukemia Independent of the BCR-ABL Status

Activating CBL mutations are associated with a distinct MDS/MPN phenotype

Frequency and Clinical Presentation of Polycomb Repressive Complex 2 (PRC2) Component Mutations in Childhood Acute Lymphoblastic Leukemia

Suchergebnisse filtern